Skip to main content
logo
Nemetschek SE (NEMKY)
OTCMKTS · Delayed Price · Currency is USD
29.98
-0.07 (-0.23%)
At close: Jul 8, 2025

Oncternal Therapeutics Revenue

Nemetschek SE had revenue of 290.03M EUR in the quarter ending June 30, 2025, with 27.38% growth. This brings the company's revenue in the last twelve months to 1.12B, up 25.33% year-over-year. In the year 2024, Nemetschek SE had annual revenue of 995.57M with 16.91% growth.

Revenue (ttm)
1.12B EUR
Revenue Growth
+25.33%
P/S Ratio
12.52
Revenue / Employee
286.79K EUR
Employees
3,894
Market Cap
16.42B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024995.57M144.00M16.91%
Dec 31, 2023851.56M49.75M6.20%
Dec 31, 2022801.81M120.34M17.66%
Dec 31, 2021681.47M84.57M14.17%
Dec 31, 2020596.91M40.03M7.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jingbo Technology2.29M
IPE Universal17.33M
AI Unlimited Group101.00
Rand Worldwide86.70M
Applied Energetics2.50M
Abaxx Technologies601.14K
Fast Finance Pay10.35M
EACO Corporation401.98M
Revenue Rankings

Nemetschek SE News

More News